Dermata Therapeutics, Inc. (DRMA) Misses Q1 EPS by 27c

Dermata Therapeutics, Inc. (NASDAQ: DRMA) reported Q1 EPS of ($0.47), $0.27 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Dermata Therapeutics, Inc. (DRMA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Bernstein SocGen Reiterates Outperform Rating on Fervo Energy (FRVO)
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance